FDA Brief

Company record

Smitha C. Reddy, M.D./ACRC Studies, LLC

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Smitha C. Reddy, M.D./ACRC Studies, LLC.

Warning letters

  1. Smitha C. Reddy, M.D./ACRC Studies, LLC

    FDA warns Dr. Smitha Reddy over clinical trial protocol violations, including wrong drug given and broken blinding.

    High risk